Insider Transactions Reported by 12 Insiders of Vanda Pharmaceuticals Inc.

Symbol
VNDA on Nasdaq
Location
Washington, DC

Insiders trading volume in the past year

Vanda Pharmaceuticals Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Mihael H. Polymeropoulos President and CEO, Director, Chairman of the Board $22,256,487 +$317,367 +1.4% 18 Feb 2026
Gunther Birznieks SVP, Business Development $4,174,965 18 Feb 2026
Kevin Patrick Moran SVP, CFO & Treasurer $3,535,675 18 Feb 2026
Timothy Williams SVP & General Counsel $3,266,697 18 Feb 2026
Joakim Wijkstrom SVP, Chief Marketing Officer $2,834,012 18 Feb 2026
Tage Honore Director $750,556 -$240,900 -24% 23 Feb 2026
Richard W. Dugan Director $700,943 05 Jun 2025
Phaedra Chrousos Director $487,232 05 Jun 2025
Aranthan S. Jones II Chief Corp. Affairs Officer $478,763 15 Sep 2021
Anne Sempowski Ward Director $470,314 05 Jun 2025
Stephen Ray Mitchell Director $445,606 -$32,130 -6.7% 13 Jun 2025
Thomas Watkins Director $368,294 02 Jun 2022

Recent Insider Transactions by Companies or Individuals for Vanda Pharmaceuticals Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.